Accuray Operating Margin 2011-2025 | ARAY
Current and historical operating margin for Accuray (ARAY) over the last 10 years. The current operating profit margin for Accuray as of September 30, 2025 is -4.54%.
| Accuray Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.45B | $0.00B | -0.22% |
| 2025-06-30 | $0.46B | $0.01B | 1.74% |
| 2025-03-31 | $0.47B | $0.01B | 2.37% |
| 2024-12-31 | $0.45B | $0.01B | 1.10% |
| 2024-09-30 | $0.44B | $0.00B | -0.90% |
| 2024-06-30 | $0.45B | 0 | 0.00% |
| 2024-03-31 | $0.43B | $-0.01B | -1.63% |
| 2023-12-31 | $0.45B | 0 | 0.00% |
| 2023-09-30 | $0.46B | $0.01B | 1.54% |
| 2023-06-30 | $0.45B | $0.00B | 0.67% |
| 2023-03-31 | $0.44B | $0.01B | 1.14% |
| 2022-12-31 | $0.42B | $0.00B | 0.72% |
| 2022-09-30 | $0.42B | $0.00B | 0.96% |
| 2022-06-30 | $0.43B | $0.01B | 1.86% |
| 2022-03-31 | $0.43B | $0.01B | 2.33% |
| 2021-12-31 | $0.44B | $0.01B | 3.20% |
| 2021-09-30 | $0.42B | $0.02B | 4.31% |
| 2021-06-30 | $0.40B | $0.02B | 5.30% |
| 2021-03-31 | $0.38B | $0.02B | 5.79% |
| 2020-12-31 | $0.38B | $0.03B | 6.90% |
| 2020-09-30 | $0.38B | $0.02B | 5.80% |
| 2020-06-30 | $0.38B | $0.01B | 3.39% |
| 2020-03-31 | $0.41B | $0.01B | 2.71% |
| 2019-12-31 | $0.41B | $0.01B | 1.47% |
| 2019-09-30 | $0.41B | $0.00B | 0.24% |
| 2019-06-30 | $0.42B | 0 | 0.00% |
| 2019-03-31 | $0.42B | 0 | 0.00% |
| 2018-12-31 | $0.41B | $-0.01B | -1.70% |
| 2018-09-30 | $0.41B | $-0.01B | -1.71% |
| 2018-06-30 | $0.41B | $0.00B | -0.99% |
| 2018-03-31 | $0.40B | $0.00B | -0.99% |
| 2017-12-31 | $0.40B | $0.00B | -0.25% |
| 2017-09-30 | $0.39B | $-0.01B | -1.29% |
| 2017-06-30 | $0.38B | $-0.01B | -2.60% |
| 2017-03-31 | $0.37B | $-0.02B | -4.36% |
| 2016-12-31 | $0.38B | $-0.01B | -2.67% |
| 2016-09-30 | $0.40B | $-0.01B | -1.26% |
| 2016-06-30 | $0.40B | $-0.01B | -1.25% |
| 2016-03-31 | $0.41B | $0.00B | -0.74% |
| 2015-12-31 | $0.40B | $-0.01B | -1.75% |
| 2015-09-30 | $0.39B | $-0.01B | -2.84% |
| 2015-06-30 | $0.38B | $-0.02B | -5.00% |
| 2015-03-31 | $0.38B | $-0.02B | -6.05% |
| 2014-12-31 | $0.38B | $-0.02B | -6.33% |
| 2014-09-30 | $0.38B | $-0.02B | -5.60% |
| 2014-06-30 | $0.37B | $-0.02B | -4.86% |
| 2014-03-31 | $0.35B | $-0.03B | -7.37% |
| 2013-12-31 | $0.33B | $-0.05B | -15.60% |
| 2013-09-30 | $0.31B | $-0.07B | -23.15% |
| 2013-06-30 | $0.32B | $-0.08B | -25.55% |
| 2013-03-31 | $0.33B | $-0.08B | -24.32% |
| 2012-12-31 | $0.36B | $-0.07B | -18.96% |
| 2012-09-30 | $0.39B | $-0.05B | -13.27% |
| 2012-06-30 | $0.41B | $-0.06B | -13.69% |
| 2012-03-31 | $0.38B | $-0.07B | -17.75% |
| 2011-12-31 | $0.34B | $-0.06B | -16.67% |
| 2011-09-30 | $0.28B | $-0.05B | -16.55% |
| 2011-06-30 | $0.22B | $-0.03B | -12.61% |
| 2011-03-31 | $0.21B | $0.00B | 1.44% |
| 2010-12-31 | $0.21B | $0.01B | 3.40% |
| 2010-09-30 | $0.21B | $0.00B | 0.48% |
| 2010-06-30 | $0.22B | $0.00B | 1.35% |
| 2010-03-31 | $0.22B | $0.00B | -1.37% |
| 2009-12-31 | $0.23B | $-0.01B | -2.19% |
| 2009-09-30 | $0.23B | $0.00B | -0.87% |
| 2009-06-30 | $0.23B | $0.00B | -0.85% |
| 2009-03-31 | $0.23B | $0.00B | -1.33% |
| 2008-12-31 | $0.22B | $-0.01B | -2.23% |
| 2008-09-30 | $0.22B | $-0.01B | -2.29% |
| 2008-06-30 | $0.21B | $0.00B | -0.47% |
| 2008-03-31 | $0.20B | $-0.01B | -5.39% |
| 2007-12-31 | $0.18B | $-0.01B | -6.59% |
| 2007-09-30 | $0.16B | $-0.02B | -12.82% |
| 2007-06-30 | $0.14B | $-0.02B | -13.57% |
| 2007-03-31 | $0.11B | $-0.02B | -14.29% |
| 2006-12-31 | $0.09B | $-0.02B | -25.58% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.120B | $0.459B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.010B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $194.409B | 76.06 |
| IDEXX Laboratories (IDXX) | United States | $56.231B | 55.85 |
| Edwards Lifesciences (EW) | United States | $48.211B | 32.33 |
| Alcon (ALC) | Switzerland | $38.868B | 26.27 |
| IQVIA Holdings (IQV) | United States | $37.851B | 21.11 |
| Mettler-Toledo (MTD) | United States | $28.470B | 33.31 |
| DexCom (DXCM) | United States | $26.115B | 36.00 |
| STERIS (STE) | Ireland | $24.712B | 25.51 |
| Waters (WAT) | United States | $22.941B | 30.34 |
| Hologic (HOLX) | United States | $16.718B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.969B | 0.00 |
| Penumbra (PEN) | United States | $12.219B | 85.96 |
| Globus Medical (GMED) | United States | $11.604B | 24.35 |
| Masimo (MASI) | United States | $7.431B | 23.81 |
| Glaukos (GKOS) | United States | $6.253B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.835B | 18.54 |
| Teleflex (TFX) | United States | $5.607B | 8.94 |
| TransMedics (TMDX) | United States | $4.333B | 51.33 |
| LivaNova (LIVN) | United Kingdom | $3.427B | 18.51 |
| Veracyte (VCYT) | United States | $3.386B | 38.60 |
| Alphatec Holdings (ATEC) | United States | $2.965B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.548B | 11.96 |
| Elekta AB (EKTAY) | Sweden | $2.183B | 20.42 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| PROCEPT BioRobotics (PRCT) | United States | $2.011B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.826B | 15.94 |
| UFP Technologies (UFPT) | United States | $1.692B | 22.35 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| AxoGen (AXGN) | United States | $1.402B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.310B | 0.00 |
| IRadimed (IRMD) | United States | $1.224B | 58.32 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.045B | 5.66 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| SiBone (SIBN) | United States | $0.807B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.640B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.621B | 36.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| AngioDynamics (ANGO) | United States | $0.541B | 0.00 |
| NeuroPace (NPCE) | United States | $0.539B | 0.00 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.85 |
| Alpha Tau Medical (DRTS) | Israel | $0.428B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.428B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| ClearPoint Neuro (CLPT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.275B | 2.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.269B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.211B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| Solana (HSDT) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.35 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |